Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of a Transdiagnostic Internet-based Treatment for Emotional Disorders

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Being aged between 18 and 70 years old.~* Meeting the DSM-IV diagnosis criteria of emotional disorder (panic disorder with or without agoraphopia, social anxiety disorder, generalized anxiety disorder, obsessive-compulsive disorder, major depression disorder and dysthimia).~* Providing written, informed consent.~* Being able to understand and read Spanish.~* Having daily acces to the Internet in their natural environment.~Exclusion Criteria:~* Being diagnosed a severe mental disorder (people with the following mental disorders will be excluded from the study: schizophrenia, bipolar disorder and personality disorders from clusters A and B).~* Being diagnosed an alcohol and/or substance dependence disorder.~* The presence of high suicidal risk.~* A medical disease or condition which prevent the participant from carry out the psychological treatment.~* Receiving another psychological treatment while the study is still ongoing.~* The increase and/or changes in the medication of participants receiving pharmacological treament during the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Transdiagnostic Internet-based Treatment (Type: EXPERIMENTAL): Intervention group that carries out the Emotion Regulation Protocol and receives support by the therapist (a brief weekly two-minute phone call without clinical content and two weekly orientative text messages)
- Treatment as Usual (Type: EXPERIMENTAL): Intervention group that receives psychological and/or pharmacological treatment from a clinician of the mental health unit.

Based on this trial design, predict the completion outcome and termination type (if applicable).